Portfolio
Portfolio

Dyne Therapeutics

Dyne focuses on transforming the lives of people with serious muscle diseases by pioneering muscle-targeted therapies.

Dyne focuses on transforming the lives of people with serious muscle diseases by pioneering muscle-targeted therapies. Dyne’s proprietary technologies provide the foundation for breakthrough treatments in myotonic dystrophy, Duchenne muscular disease and others. The company is based in Boston and assembled a world-class team of drug development experts.

  • CEO Joshua Brumm
  • Industry Biotech